Predicting new-onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study

Nasrien E. Ibrahim, Asya Lyass, Hanna K. Gaggin, Yuyin Liu, Roland R. J. Van Kimmenade, Shweta R. Motiwala, Noreen P. Kelly, Parul U. Gandhi, Mandy L. Simon, Arianna M. Belcher, Jamie E. Harisiades, Joseph M. Massaro, Ralph B. D'Agostino, James L. Januzzi*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)

Abstract

AimsMethods to identify patients at risk for incident HF would be welcome as such patients might benefit from earlier interventions. Methods and resultsFrom a registry of 1251 patients referred for coronary and/or peripheral angiography, we sought to identify independent predictors of incident HF during follow-up and develop a clinical and biomarker strategy to predict this outcome. There were 991 patients free of prevalent HF at baseline. Cox proportional hazard models were developed to predict adjudicated diagnosis of incident HF. Model discrimination and reclassification were evaluated. At follow-up, 177 (18%) developed new-onset HF. Independent predictors of new-onset HF included five clinical variables (age, male sex, heart rate, history of atrial fibrillation/flutter, and history of hypertension) and two biomarkers (amino-terminal pro-B type natriuretic peptide and ST2). The c-statistic for the model without biomarkers was 0.69; including biomarkers increased the c-statistic to 0.76 (P<0.001). A score was developed from the model. Patients in the highest score quintile had shortest time to incident HF compared with lower quintiles (log-rank P<0.001). Following 100 bootstrap iterations, internal validation was confirmed with Harrell's c-statistic of 0.77. Use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers at enrollment was associated with substantial attenuation of predictive value of the risk score. ConclusionsPatients undergoing coronary/peripheral angiographic procedures are a population at high risk for incident HF. We describe an accurate clinical and biomarker strategy for predicting incident HF and possibly intervening in such patients (NCT00842868).
Original languageEnglish
Pages (from-to)240-248
Number of pages9
JournalEsc heart failure
Volume5
Issue number3
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • HF
  • Biomarker
  • Diagnosis
  • Score
  • BRAIN NATRIURETIC PEPTIDE
  • PRESERVED EJECTION FRACTION
  • HEART-FAILURE
  • EMERGENCY-DEPARTMENT
  • RENAL-FUNCTION
  • RISK
  • MANAGEMENT
  • SCORE
  • MORTALITY
  • SYMPTOMS
  • CHRONIC HEART-FAILURE
  • DYSPNEA
  • ST2
  • OUTCOMES
  • Prognosis
  • Angiography
  • Follow-Up Studies
  • Humans
  • Male
  • Massachusetts/epidemiology
  • Incidence
  • Heart Failure/blood
  • Time Factors
  • Catheterization/methods
  • Biomarkers/blood
  • Female
  • Registries
  • Retrospective Studies
  • Risk Assessment/methods
  • Peripheral Arterial Disease/complications
  • Coronary Artery Disease/complications
  • Aged
  • Peptide Fragments/blood
  • Natriuretic Peptide, Brain/blood

Cite this